Medpace Holdings Inc (MEDP) News & Events

$669.195

+15.592 (+2.33%)At close

MEDP News

Medpace Reports Record New Business Awards in Q3 2026

Medpace CEO Sells Shares, Market Reaction Remains Steady

Medpace CEO Sells 15,978 Shares for $10 Million

Kuehn Law Investigates Medpace Executives for Breach of Duties

Biotech Stocks Reach 52-Week Highs Following Key Catalysts

Biotech Stocks Surge with Advanced Biomed Leading Gains

Medpace Reports Strong Q2 2026 Earnings with Record Net Bookings

Medpace Q2 Financials Exceed Expectations, Stock Soars

Medpace Stock Surges Double Digits on Strong Bookings Beat

Mixed Earnings Reports from Multiple Companies

10/21 16:30

Company Reports Q3 Revenue of $716M

Reports Q3 revenue $716M, consensus $714.44M.

10/21 16:30

Company Narrows FY26 Revenue Outlook to $2.835B

Consensus $17.72. Narrows FY26 revenue view to $2.835B-$2.855B from $2.805B-$2.885B, consensus $2.85B.

7/23 12:30

Medpace Stock Rises 12.7% to $595.00

Medpace is up 12.7%, or $66.88 to $595.00.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.